HOME > TOP STORIES

TOP STORIES

REGULATORY Price Gap between Long-Listed Products, Generics Should Be Retained: Mr Chikazawa of MHLW

September 28, 2012
BUSINESS Takeda Aims to Become No. 1 in Domestic Diabetes, Cardiovascular Markets: Senior Vice Pres. Iwasaki

September 27, 2012
BUSINESS Japan Vaccine Pres. Nagano Eyes One-Third Market Share or More in FY2020

September 26, 2012
BUSINESS Sanofi-Aventis Looks to Clinical Evidence to Differentiate Lantus from Rival

September 25, 2012
ORGANIZATION MHLW Reports Results of Analysis of “Close-Call” Incidents at Pharmacies with Generics

September 24, 2012
BUSINESS Pfizer Preparing for Assault on Domestic Generic Drug Market with Help from Mylan

September 24, 2012
REGULATORY MHLW to Introduce Brand Name Rules for Combination Injectables to Prevent Medical Accidents

September 21, 2012
ORGANIZATION Dr Fukuda Lays Out 4 Options for HTA Introduction in Drug Pricing

September 20, 2012
ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences

September 19, 2012
BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin

September 18, 2012
BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug

September 14, 2012
REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27

September 12, 2012
BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September

September 12, 2012
BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs

September 11, 2012
BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?

September 10, 2012
BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage

September 7, 2012
BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field

September 6, 2012
BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis

September 5, 2012
BUSINESS RaQualia to Focus on Fields Where It Can Exhibit Uniqueness, Compile Biz Strategy in November

September 4, 2012
BUSINESS DSP’s US Subsidiary Sunovion to Acquire Elevation Pharmaceuticals of the US

September 3, 2012

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…